A single-arm, open-label trial study of THX-RS01 in treating Tourette syndrome

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Feb 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 Aug 2018 According to a Therapix Biosciences media release, the results were presented at the annual meeting of the European Society for the Study of Tourette Syndrome 2018.
11 Jun 2018 According to Therapix Biosciences Ltd. media release, the results from this study will be presented at the 11th European Society for the Study of Tourette Syndrome (ESSTS) conference in June.
31 May 2018 Status changed from active, no longer recruiting to completed, according to a herapix Biosciences media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com